605 results on '"Bonavita, Simona"'
Search Results
2. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis
3. Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning
4. Clinical implications for the association of psoriasis and multiple sclerosis: an observational study
5. Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis
6. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
7. NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
8. Viral pericarditis following ocrelizumab in a multiple sclerosis patient
9. MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles
10. Validation of the swallowing disturbance questionnaire in people with multiple sclerosis
11. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective
12. Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis
13. Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
14. Machine learning techniques for prediction of multiple sclerosis progression
15. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
16. Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
17. Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab
18. Reduced clinical connectome fingerprinting in multiple sclerosis predicts fatigue severity
19. Telemedicine application to headache: a critical review
20. Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study
21. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
22. Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study
23. Pain, quality of life, and religiosity in people with multiple sclerosis
24. Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
25. PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study
26. Disability assessment using Google Maps
27. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
28. Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)
29. Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
30. The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment
31. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
32. Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment
33. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study
34. Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis
35. Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
36. Coping strategies in relapsing–remitting multiple sclerosis non-depressed patients and their associations with disease activity
37. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
38. Psychiatric disorders in multiple sclerosis
39. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
40. Flexibility of brain dynamics is increased and predicts clinical impairment in relapsing–remitting but not in secondary progressive multiple sclerosis.
41. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
42. Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
43. Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod
44. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
45. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
46. Gait abnormalities in minimally disabled people with Multiple Sclerosis: A 3D-motion analysis study
47. Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online
48. Severe lymphopenia switching from Fingolimod to Siponimod
49. Vitamin D Supplementation: Effect on Cytokine Profile in Multiple Sclerosis.
50. Cost-Analysis of Telemedicine Interventions Compared with Traditional Care in the Management of Chronic Neurological Diseases: A Systematic Review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.